By Claire Jeong, Chief Conference Officer, Vice President of Investor Research, Asia BD, LSN
At RESI Europe 2026 in Lisbon, more than 20 innovative companies participated in the Innovator’s Pitch Challenge (IPC), showcasing cutting-edge technologies across drugs, devices, diagnostics, and digital health. The IPC continues to serve as a powerful platform for early-stage life science companies to engage directly with active investors and strategic partners.
Each finalist delivered a 6-minute pitch followed by a 7-minute live Q&A with a panel of investor judges, creating a dynamic and interactive evaluation process. Beyond the stage, participating companies also connected with attendees through dedicated poster presentations and 1:1 partnering meetings, maximizing visibility and investor engagement throughout the event.
A defining feature of the IPC is the RESI cash voting system. Registered attendees, including investors, startup executives, and industry experts, allocated their RESI cash to the companies they found most compelling. Voting was based on pitch performance, Q&A responses, and direct interactions during partnering meetings and networking sessions.
Life Science Nation is proud to announce the top three winners of the RESI Europe 2026 Innovator’s Pitch Challenge:
| 1st Place | 2nd Place | 3rd Place |
 |
 |
 |
| StimOxyGen | Amets Biotechnology | You2Yourself |
These companies stood out for their strong scientific foundations, clear value propositions, and ability to engage investor interest.
Applications are now open for upcoming Innovator’s Pitch Challenges. Companies can apply to pitch at RESI San Diego 2026 and take the stage in front of a global network of investors and partners.
| Apply to Pitch at RESI San Diego |
Next Phase Newsletter 
Leave a comment